Mary Spellman

Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults

Journal of the American Academy of Dermatology · 2016 · 417 citations

Long-term safety of crisaborole ointment 2% in children and adults with mild to moderate atopic dermatitis

Journal of the American Academy of Dermatology · 2017 · 111 citations